首页> 外文期刊>Urology >Tubular dysplasia and carcinoma in situ: precursors of renal cell carcinoma.
【24h】

Tubular dysplasia and carcinoma in situ: precursors of renal cell carcinoma.

机译:肾小管发育不良和原位癌:肾细胞癌的前体。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To identify the dysplastic changes in tubules adjacent to or remote from renal cell carcinoma (RCC) and to assess proliferating cell nuclear antigen (PCNA) expression of normal tubule and carcinoma cells. METHODS: The study analyzed 62 kidneys with RCC that were removed by radical nephrectomy. Pathologic sections were stained with hematoxylin-eosin and evaluated for the presence of dysplasia. Sections that contained dysplasia were then stained by the avidin-biotin immunoperoxidase technique after epitope retrieval for PCNA. RESULTS: Dysplastic changes in normal kidney were identified in 14 cases (23%). Dysplastic changes were adjacent to the tumor in 10 cases. Dysplasia was adjacent to the tumor and diffuse in 6 cases (3 clear cell [CRCC], 2 chromophobe [ChRCC], 1 sarcomatoid RCC [SRCC]), adjacent to the tumor and focal in 4 cases (2 CRCC, 1 papillary RCC, 1 SRCC), remote and focal in 3 cases (1 granular RCC, 1 ChRCC, 1 SRCC), and remote and diffuse in 1 case (CRCC). The lesions represented a focus that could be defined as carcinoma in situ in 3 cases. PCNA immunostaining in dysplastic epithelia was more intense than that in normal tubules and was as intense or even more intense than that in carcinoma cells. CONCLUSIONS: Dysplasia of tubular epithelium is probably a biologic precursor of at least some RCC. Tubular dysplasia warrants further study as an important phase that will provide new insights into the pathogenesis, biologic behavior, and natural history of RCC. Its impact on the surgical management of small unilateral RCC needs to be investigated.
机译:目的:鉴定邻近或远离肾细胞癌(RCC)的肾小管增生异常,并评估正常肾小管和癌细胞的增殖细胞核抗原(PCNA)表达。方法:该研究分析了通过根治性肾切除术切除的62例RCC肾脏。病理切片用苏木精-伊红染色,并评估是否存在异型增生。在针对PCNA的表位修复后,通过抗生物素蛋白-生物素免疫过氧化物酶技术对含有异型增生的切片进行染色。结果:在正常肾脏中发现增生异常改变14例(23%)。异常增生性改变与肿瘤相邻10例。异型增生在肿瘤附近并扩散,有6例(3个透明细胞[CRCC],2个发色团[ChRCC],1个肉瘤样RCC [SRCC]),在肿瘤和病灶附近4例(2个CRCC,1个乳头状RCC, 1个SRCC),3例(1个颗粒状RCC,1个ChRCC,1个SRCC)为远程和焦点,1例(CRCC)为远程和弥散。病变代表了一个焦点,可将其定义为3例原位癌。增生异常上皮中的PCNA免疫染色比正常肾小管中的PCNA更为强烈,与癌细胞中的PCNA一样甚至更高。结论:肾小管上皮发育异常可能是至少一些RCC的生物学前体。管状不典型增生值得进一步研究,作为一个重要阶段,它将为RCC的发病机制,生物学行为和自然病史提供新的见解。它对小型单侧RCC的外科治疗的影响有待研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号